DAILY VALAVAN SHARE MARKET
Buy : AUROBINDO PHARMA
ENTRY PRICE : 791
PERIOD. 1 MONTH
52 WEEK HIGH. 890.50
52 WEEK LOW. 582
Aurobindo pharma ends 5% up, gets FDA nod for Rosuvastatin Calcium tables.
Strong Q4 show with beat on revenues and PAT driven by robust US sales.
TOMORROW WE WILL MEET WITH ANOTHER RECOMMENDATION.
Share information disclaimer
The share information contained in this blog is not intended to provide professional advice and should not be relied upon in that regard. Valavan-teentonic.blogspot does not guarantee its accuracy or reliability and accepts no liability (whether in tort or contract or otherwise) for any loss or damage whatsoever arising from any inaccuracies or omissions.
Please note the market information and all quotes are delayed by at least 15 minutes.